Scinovex
review Open AccessTop 1% cited

Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome

Alimentary Pharmacology & Therapeutics · 2018 · Vol. 48(10) · pp. 1044–1060
Alexander C. FordLucinda A. HarrisBrian E. LacyEamonn M.M. QuigleyPaul Moayyedi

Abstract

Which particular combination, species or strains of probiotics are effective for IBS remains, for the most part, unclear. Rifaximin has modest efficacy in improving symptoms in non-constipated IBS.

Gastrointestinal motility and disordersInfant Health and DevelopmentComplementary and Alternative Medicine StudiesSynbioticsMedicineIrritable bowel syndromeRifaximinInternal medicinePlaceboRandomized controlled trialMeta-analysisAdverse effectGastroenterology

MeSH terms

Gastrointestinal MicrobiomeRifaximinAdultAnti-Bacterial AgentsGastrointestinal AgentsHumansAbdominal PainRandomized Controlled Trials as TopicTreatment OutcomeProbioticsIrritable Bowel SyndromePrebioticsSynbiotics

Funding

  • Health Research
  • American College of Gastroenterology
Citations
594
FWCI
44.80
field-weighted impact
References
104
Percentile
100%
vs. same field & year
Citations per year
Cited by
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
The American Journal of Gastroenterology · 2020 · 760 citations
References
Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
The American Journal of Gastroenterology · 2000 · 770 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.